tirzepatide and mounjaro (Tirzepatide) Side Effects: What To Know Mounjaro Tirzepatide Injections for Weight

Key takeaways Semaglutide is a glucagon-like peptide-1 receptor agonist thats often prescribed for glycemic control in individuals with diabetes or weight management in people with obesity

Magnesium glycinate

This dual mechanism is what differentiates tirzepatide from earlier therapies

How to Adjust Your Training When Taking a GLP-1 (Without Quitting Altogether) Here are some tricks to make training more accessible even when the body is going through changes associated with GLP-1s

If nausea persists beyond 3-4 weeks on a stable dose, consider reducing to the previous dose level and attempting re-escalation more gradually after 4-6 weeks

Glucagon-like peptide-1 receptor agonists are similar to the GLP-1 hormone, which is secreted in the gastrointestinal tract in response to eating